Safety and immunogenicity of inactivated COVID-19 vaccine CoronaVac and the RBD-dimer–based COVID-19 vaccine ZF2001 in chronic hepatitis B patients

BACKGROUND AND AIMS: Although COVID-19 vaccination is recommended for the patients with chronic liver disease, the clinical outcomes of COVID-19 vaccinated in patients with chronic hepatitis B (CHB) has not been well characterized. The study aimed to explore the safety and specific antibody response...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shiheng, Wang, Xiaolin, Feng, Mingyang, Liu, Xiaoman, Fan, Xinxing, Ran, Xiangui, Wang, Baogui, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944390/
https://www.ncbi.nlm.nih.gov/pubmed/36844234
http://dx.doi.org/10.3389/fmed.2023.1078666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944390/
https://www.ncbi.nlm.nih.gov/pubmed/36844234
http://dx.doi.org/10.3389/fmed.2023.1078666

Ejemplares similares